Background/Objectives: Pediatric cancer patients and their families are increasingly combining conventional treatment with complementary therapies. These therapies are not covered by most public healthcare systems, and Spain is not an exception. To address this need, the Pediatric Cancer Center Barcelona, at the Hospital Sant Joan de Déu (Spain), established the first integrative pediatric oncology unit in 2019. The objective of this study is to describe the feasibility of implementing a pediatric integrative oncology unit, in terms of the acceptance of the interventions, as well as to present initial data on the care activities; Methods: This is a retrospective single-center study, conducted in the Pediatric Cancer Center Barcelona, at the Hospital Sant Joan de Déu. Data from patients during a two-year period were collected by reviewing medical records in a pseudonymous manner; Results: From 1 September 2019 to 30 September 2021, the unit was visited by 433 patients. The median age of patients was 9 years [range 0–34 years], with 266 boys (61.4%) and 167 girls (38.6%). Of these patients, 90.1% were in active treatment, 7.6% were survivors, and 2.3% were at the end of life. Acupuncture was recommended to 227 patients, with a 94.7% acceptance rate. Aromatherapy was recommended to 114 patients, with a 100% acceptance. The reflexology team visited 129 patients, delivering a total of 414 sessions, with a 96.1% acceptance.; Conclusions: The findings of our study support the feasibility of implementing an Integrative Pediatric Oncology Unit within a patient-centered care model in a comprehensive pediatric cancer center. The high acceptance rates of various complementary therapies highlight their potential role in enhancing supportive care for pediatric oncology patients.
背景/目的：儿科癌症患者及其家庭越来越多地将常规治疗与补充疗法相结合。这些疗法在大多数公共医疗系统中未被覆盖，西班牙也不例外。为满足这一需求，巴塞罗那圣琼德德医院儿科癌症中心于2019年设立了首个综合性儿科肿瘤科。本研究旨在从干预措施接受度的角度，描述实施儿科综合性肿瘤科的可行性，并呈现初步的护理活动数据；方法：这是一项在巴塞罗那圣琼德德医院儿科癌症中心进行的回顾性单中心研究。通过匿名方式审查医疗记录，收集了两年期间患者的数据；结果：从2019年9月1日至2021年9月30日，该科室共接诊了433名患者。患者中位年龄为9岁[范围0-34岁]，其中男孩266名（61.4%），女孩167名（38.6%）。在这些患者中，90.1%处于积极治疗阶段，7.6%为幸存者，2.3%处于临终阶段。227名患者被推荐接受针灸治疗，接受率为94.7%。114名患者被推荐接受芳香疗法，接受率为100%。反射疗法团队接诊了129名患者，共进行了414次治疗，接受率为96.1%；结论：我们的研究结果支持在以患者为中心的护理模式下，在综合性儿科癌症中心实施综合性儿科肿瘤科的可行性。各种补充疗法的高接受率突显了它们在增强儿科肿瘤患者支持性护理中的潜在作用。
肿瘤(癌症)患者之家